ILARIS canakinumab 150mg/1mL solution for injection in vials

Approval Id: 41ce8246f56c2e31
Product Name: ILARIS canakinumab 150mg/1mL solution for injection in vials
Artg Id: 279239
Artg Name: ILARIS canakinumab (rmc) 150mg/1mL solution for injection in vials
Sponsor: Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date: 2017-05-26
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/f08b9faeb3d766857380219953d96149.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/cc747173b4e83f86c61369457b5d1ce2.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

41ce8246f56c2e31

Type

Standard